BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 25690296)

  • 1. Anti-proliferative effect and induction of apoptosis in androgen-independent human prostate cancer cells by 1,5-bis(2-hydroxyphenyl)-1,4-pentadiene-3-one.
    Citalingam K; Abas F; Lajis NH; Othman I; Naidu R
    Molecules; 2015 Feb; 20(2):3406-30. PubMed ID: 25690296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Curcumin Analogue, MS13 (1,5-Bis(4-hydroxy-3- methoxyphenyl)-1,4-pentadiene-3-one), Inhibits Cell Proliferation and Induces Apoptosis in Primary and Metastatic Human Colon Cancer Cells.
    Ismail NI; Othman I; Abas F; H Lajis N; Naidu R
    Molecules; 2020 Aug; 25(17):. PubMed ID: 32825505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Curcumin Analogue 1,5-Bis(2-hydroxyphenyl)-1,4-pentadiene-3-one Induces Apoptosis and Downregulates E6 and E7 Oncogene Expression in HPV16 and HPV18-Infected Cervical Cancer Cells.
    Paulraj F; Abas F; Lajis NH; Othman I; Hassan SS; Naidu R
    Molecules; 2015 Jun; 20(7):11830-60. PubMed ID: 26132907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diarylpentanoid (1,5-bis(4-hydroxy-3-methoxyphenyl)-1,4-pentadiene-3-one) (MS13) Exhibits Anti-proliferative, Apoptosis Induction and Anti-migration Properties on Androgen-independent Human Prostate Cancer by Targeting Cell Cycle-Apoptosis and PI3K Signalling Pathways.
    Abd Wahab NA; Abas F; Othman I; Naidu R
    Front Pharmacol; 2021; 12():707335. PubMed ID: 34366863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Mechanisms of Antiproliferative and Apoptosis Activity by 1,5-Bis(4-Hydroxy-3-Methoxyphenyl)1,4-Pentadiene-3-one (MS13) on Human Non-Small Cell Lung Cancer Cells.
    Wan Mohd Tajuddin WNB; Abas F; Othman I; Naidu R
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of 1,7-diheteroarylhepta-1,4,6-trien-3-ones as curcumin-based anticancer agents.
    Wang R; Zhang X; Chen C; Chen G; Zhong Q; Zhang Q; Zheng S; Wang G; Chen QH
    Eur J Med Chem; 2016 Mar; 110():164-80. PubMed ID: 26827161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A monocarbonyl analogue of curcumin, 1,5-bis(3-hydroxyphenyl)-1,4-pentadiene-3-one (Ca 37), exhibits potent growth suppressive activity and enhances the inhibitory effect of curcumin on human prostate cancer cells.
    Luo C; Li Y; Zhou B; Yang L; Li H; Feng Z; Li Y; Long J; Liu J
    Apoptosis; 2014 Mar; 19(3):542-53. PubMed ID: 24297639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and biological evaluation of 1,9-diheteroarylnona-1,3,6,8-tetraen-5-ones as a new class of anti-prostate cancer agents.
    Zhang X; Wang R; Perez GR; Chen G; Zhang Q; Zheng S; Wang G; Chen QH
    Bioorg Med Chem; 2016 Oct; 24(19):4692-4700. PubMed ID: 27543391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor agents. 250. Design and synthesis of new curcumin analogues as potential anti-prostate cancer agents.
    Lin L; Shi Q; Nyarko AK; Bastow KF; Wu CC; Su CY; Shih CC; Lee KH
    J Med Chem; 2006 Jun; 49(13):3963-72. PubMed ID: 16789753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DK1 Induces Apoptosis via Mitochondria-Dependent Signaling Pathway in Human Colon Carcinoma Cell Lines In Vitro.
    Hussin Y; Aziz MNM; Che Rahim NF; Yeap SK; Mohamad NE; Masarudin MJ; Nordin N; Abd Rahman NMA; Yong CY; Akhtar MN; Zamrus SNH; Alitheen NB
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29641445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor agents. 217. Curcumin analogues as novel androgen receptor antagonists with potential as anti-prostate cancer agents.
    Ohtsu H; Xiao Z; Ishida J; Nagai M; Wang HK; Itokawa H; Su CY; Shih C; Chiang T; Chang E; Lee Y; Tsai MY; Chang C; Lee KH
    J Med Chem; 2002 Nov; 45(23):5037-42. PubMed ID: 12408714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-targeted apoptosis by a novel spermine analogue, 1,12-diaziridinyl-4,9-diazadodecane, results in therapeutic efficacy and enhanced radiosensitivity of human prostate cancer.
    Eiseman JL; Rogers FA; Guo Y; Kauffman J; Sentz DL; Klinger MF; Callery PS; Kyprianou N
    Cancer Res; 1998 Nov; 58(21):4864-70. PubMed ID: 9809992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor apoptosis induced by epoxide-containing piperazines, a new class of anti-cancer agents.
    Eilon GF; Gu J; Slater LM; Hara K; Jacobs JW
    Cancer Chemother Pharmacol; 2000; 45(3):183-91. PubMed ID: 10663635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of some novel triazole hybrids of curcumin mimics and their selective anticancer activity against breast and prostate cancer cell lines.
    Mandalapu D; Saini KS; Gupta S; Sharma V; Yaseen Malik M; Chaturvedi S; Bala V; Hamidullah ; Thakur S; Maikhuri JP; Wahajuddin M; Konwar R; Gupta G; Sharma VL
    Bioorg Med Chem Lett; 2016 Sep; 26(17):4223-32. PubMed ID: 27496212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and evaluation of novel heteroaromatic analogs of curcumin as anti-cancer agents.
    Samaan N; Zhong Q; Fernandez J; Chen G; Hussain AM; Zheng S; Wang G; Chen QH
    Eur J Med Chem; 2014 Mar; 75():123-31. PubMed ID: 24531225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin induces cell cycle arrest and apoptosis of prostate cancer cells by regulating the expression of IkappaBalpha, c-Jun and androgen receptor.
    Guo H; Xu YM; Ye ZQ; Yu JH; Hu XY
    Pharmazie; 2013 Jun; 68(6):431-4. PubMed ID: 23875250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of curcumin analogues for inhibiting human prostate cancer cells and the growth of human PC-3 prostate xenografts in immunodeficient mice.
    Zhou DY; Ding N; Van Doren J; Wei XC; Du ZY; Conney AH; Zhang K; Zheng X
    Biol Pharm Bull; 2014; 37(6):1029-34. PubMed ID: 24647337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo.
    Dorai T; Cao YC; Dorai B; Buttyan R; Katz AE
    Prostate; 2001 Jun; 47(4):293-303. PubMed ID: 11398177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulators of estrogen receptor inhibit proliferation and migration of prostate cancer cells.
    Piccolella M; Crippa V; Messi E; Tetel MJ; Poletti A
    Pharmacol Res; 2014 Jan; 79():13-20. PubMed ID: 24184124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Induction of apoptosis by mifepristone in androgen-independent prostate cancer cell lines in vitro].
    Zhang H; Lü JJ; Gao QZ; Zhang J
    Zhonghua Wai Ke Za Zhi; 2006 Mar; 44(6):382-5. PubMed ID: 16638347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.